Dermata Therapeutics Inc. Gains 32.73%

Thu, Jul 07, 2022 at 08:37 PM
Dermata Therapeutics Inc. Gains 32.73%

Dermata Therapeutics Inc. (DRMA:NASDAQ) jumped higher at $0.69, representing a gain of 32.7%. On Thu, Jul 07, 2022, DRMA:NASDAQ touched a New 2-Week High of $0.69. The stock got featured on our News Catalysts scanner on Mon, Jun 13, 2022 at 09:25 AM in the 'BIOTECH' category. From Fri, Jun 24, 2022, the stock recorded 75.00% Up Days and 44.44% Green Days

The stock spiked on Thu, Jun 30, 2022 at $1.04 with a volume of 29M+.

About Dermata Therapeutics Inc. (DRMA:NASDAQ)

Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.